These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35354542)

  • 1. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
    Zhu W; Tan L; Ma T; Yin Z; Gao J
    Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA SNHG8 promotes proliferation and invasion of gastric cancer cells by targeting the miR-491/PDGFRA axis.
    Zhang P; Li S; Chen Z; Lu Y; Zhang H
    Hum Cell; 2020 Jan; 33(1):123-130. PubMed ID: 31620977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z; Si J; Nan J
    Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
    Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
    Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
    [No Abstract]   [Full Text] [Related]  

  • 6. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Oncol; 2021 Jan; 15(1):299-316. PubMed ID: 32460412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RP11-81H3.2 promotes gastric cancer progression through miR-339-HNRNPA1 interaction network.
    Chen FR; Sha SM; Wang SH; Shi HT; Dong L; Liu D; Cheng Y; An M; Wang Y; Zhang J
    Cancer Med; 2020 Apr; 9(7):2524-2534. PubMed ID: 32052594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNHG15-mediated feedback loop interplays with HNRNPA1/SLC7A11/GPX4 pathway to promote gastric cancer progression.
    Duan Y; Yan Y; Fu H; Dong Y; Li K; Ye Z; Dou Y; Huang B; Kang W; Wei GH; Cai Q; Xu D; Zhou D
    Cancer Sci; 2024 Jul; 115(7):2269-2285. PubMed ID: 38720175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma.
    Liu J; Yang C; Gu Y; Li C; Zhang H; Zhang W; Wang X; Wu N; Zheng C
    Cell Mol Biol Lett; 2018; 23():17. PubMed ID: 29736176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
    Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
    Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
    Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
    Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.
    Li H; Ma X; Yang D; Suo Z; Dai R; Liu C
    J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by targeting hnRNPA1.
    Zhou B; Wang Y; Jiang J; Jiang H; Song J; Han T; Shi J; Qiao H
    IUBMB Life; 2016 Mar; 68(3):201-10. PubMed ID: 26825578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
    Guo Y; Yue P; Wang Y; Chen G; Li Y
    Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG8 promotes the development and chemo-resistance of pancreatic adenocarcinoma.
    Song Y; Zou L; Li J; Shen ZP; Cai YL; Wu XD
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8161-8168. PubMed ID: 30556854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.